-
Posted by
Two Blokes May 22 -
Filed in
Stock
-
3 views
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Vigil Neuroscience, Inc. (NASDAQ: VIGL) to Sanofi is fair to Vigil shareholders. Under the terms of the proposed transaction, Sanofi will acquire Vigil for an upfront payment of $8.00 per share of common stock in cash. Vigil shareholders will also receive a non-tradeable contingent value right entitling the holder to potentially receive an additional $2.00 per share in cash payable fol.
